1988
DOI: 10.1007/bf00916953
|View full text |Cite
|
Sign up to set email alerts
|

Class II (DR) antigen expression on CD8+ lymphocyte subsets in acquired immune deficiency syndrome (AIDS)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
12
0

Year Published

1988
1988
1999
1999

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 34 publications
(13 citation statements)
references
References 13 publications
(5 reference statements)
1
12
0
Order By: Relevance
“…HIV-speciflc CTL activity CTL activity against HlV-gag, tat, pal and env is shown in Figs I and 2 for HIV-infected (nos 1-9) and uninfected (nos [11][12][13][14][15][16][17][18][19][20] children, respectively. Results are presented as the per cent specific lysis net of medium and vaccinia controls, with values greater than 10% above controls being regarded as positive.…”
Section: Resultsmentioning
confidence: 99%
“…HIV-speciflc CTL activity CTL activity against HlV-gag, tat, pal and env is shown in Figs I and 2 for HIV-infected (nos 1-9) and uninfected (nos [11][12][13][14][15][16][17][18][19][20] children, respectively. Results are presented as the per cent specific lysis net of medium and vaccinia controls, with values greater than 10% above controls being regarded as positive.…”
Section: Resultsmentioning
confidence: 99%
“…HIV-infected patients are characterized by chronically stimulated cell-mediated immunity [20,21] and by relative CD8 ϩ lymphocytosis with a decrease in the percentage of CD28 ϩ cells but an increase in the percentage of CD28 Ϫ cells [9][10][11][12]. Therefore, freshly collected PBMCs were analyzed to evaluate the presence of CD28 dim T cells in blood samples obtained from HIV-infected patients.…”
Section: Discussionmentioning
confidence: 99%
“…It should therefore be possible to observe, in long-term-stimulated CD28 ϩ cells, the emergence in time of elements characterized by a lower CD28 molecule expression. Cells with an intermediate CD28 expression level should also be present in HIV ϩ patients, characterized by chronic activation of cell-mediated immunity [20,21]. This article describes the presence of CD8 ϩ cells with an intermediate CD28 phenotype, both at the clonal level and in freshly-collected peripheral blood mononuclear cells (PBMCs), and demonstrates that these may derive from both CD28 ϩ and CD28 Ϫ subsets, possibly as an intermediate CD28 phenotype during a normal pattern of functional CD8 ϩ T cell maturation.…”
Section: Introductionmentioning
confidence: 99%
“…In the late stages ARC and AIDS most of the CD8 + cells also carry the CD38 molecule ( Figure 5). Two colour flow cytometry using CD57 shows that CD8 + CD57 + as well as CD8 + CD57-cells expand in early HIV infection [15,16,4]. A similar expansion is seen in rejection of renal allografts [17].…”
Section: S105mentioning
confidence: 56%
“…A similar expansion is seen in rejection of renal allografts [17]. Functionally CD8 + CD38 + and CD8 + CD57 + lymphocytes are in volved in cytotoxicity against HIV-infected cellular targets [15]. In addition, antibody dependent cytotoxicity (ADCC) is triggered by antibodies to HIV antigens and may be conveyed by this cell type.…”
Section: S105mentioning
confidence: 63%